JNJ
When a giant holder trims, people notice
Sumitomo Mitsui Trust Group cut its Johnson & Johnson stake by 233,153 shares, bringing the total to about 5.95 million shares worth roughly $1.23 billion. That still makes J&J a chunky 0.7% of the portfolio, so this is less “rage quit” and more “we’re shaving the iceberg” than a full-blown exit.
The weird part? J&J is flexing
This sell-down lands right on top of a pretty solid J&J setup: Q1 revenue came in at $24.06 billion, EPS hit $2.70, and management raised full-year 2026 guidance. Oh, and it nudged the quarterly dividend up to $1.34, because apparently this company heard you like consistency and decided to overdeliver on the boring-but-beautiful stuff.
Why investors should care
On its own, one institution trimming a position is usually just portfolio housekeeping. But in a stock like JNJ, these filings can still matter because they tell you how big money is balancing valuation, safety, and yield after a strong run. Big picture: the headline is a small negative, but the underlying J&J story is still very much “steady giant, not sleepy giant.”